<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>pharmaphorum &#187; Commercial</title>
	<atom:link href="http://www.pharmaphorum.com/category/commercial/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.pharmaphorum.com</link>
	<description>Bringing Healthcare Together</description>
	<lastBuildDate>Wed, 08 Sep 2010 09:19:08 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>The pharma paradox</title>
		<link>http://www.pharmaphorum.com/2010/09/06/the-pharma-paradox/</link>
		<comments>http://www.pharmaphorum.com/2010/09/06/the-pharma-paradox/#comments</comments>
		<pubDate>Mon, 06 Sep 2010 07:34:44 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[branding]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[strategy]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2645</guid>
		<description><![CDATA[Chris Rose questions whether branding in pharma is an underrated, but viable option for protecting your assets.

Much speculation has been made about the “New Commercial Model” and how the pharma business will survive the threat of…]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/09/06/the-pharma-paradox/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>What’s in a name?</title>
		<link>http://www.pharmaphorum.com/2010/08/31/what%e2%80%99s-in-a-name/</link>
		<comments>http://www.pharmaphorum.com/2010/08/31/what%e2%80%99s-in-a-name/#comments</comments>
		<pubDate>Tue, 31 Aug 2010 09:15:51 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[reform]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2631</guid>
		<description><![CDATA[As the number of terms used in nomenclature of marketing activities increases, Chris Stevenson questions whether it’s time we standardised.

 “That which we call a rose, by any other name would smell as sweet”. We may all agree with Juliet that her lover Romeo would...
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/31/what%e2%80%99s-in-a-name/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Looking beyond pharma for portfolio optimisation</title>
		<link>http://www.pharmaphorum.com/2010/08/23/looking-beyond-pharma-for-portfolio-optimisation/</link>
		<comments>http://www.pharmaphorum.com/2010/08/23/looking-beyond-pharma-for-portfolio-optimisation/#comments</comments>
		<pubDate>Mon, 23 Aug 2010 09:19:23 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2597</guid>
		<description><![CDATA[Trevor Brown outlines an exciting new project where pharma is looking to learn from other industries about how to improve portfolio management and optimisation.

Within an increasingly challenging environment, there is significant debate in the pharmaceutical industry directed at…
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/23/looking-beyond-pharma-for-portfolio-optimisation/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Engaging OLs ‘over time’ online for greater insight</title>
		<link>http://www.pharmaphorum.com/2010/08/19/engaging-ols-%e2%80%98over-time%e2%80%99-online-for-greater-insight/</link>
		<comments>http://www.pharmaphorum.com/2010/08/19/engaging-ols-%e2%80%98over-time%e2%80%99-online-for-greater-insight/#comments</comments>
		<pubDate>Thu, 19 Aug 2010 09:08:30 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[internet]]></category>
		<category><![CDATA[market research]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[social media]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2470</guid>
		<description><![CDATA[In a time-pressured, geographically-vast industry, Neil A. Jones discusses what should be considered to ensure effective online engagement with Opinion Leaders.

Despite all the promises of the web to engage opinion leaders and other key stakeholders online for… ]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/19/engaging-ols-%e2%80%98over-time%e2%80%99-online-for-greater-insight/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
		</item>
		<item>
		<title>What Are IDEAs Made Of: Brand names</title>
		<link>http://www.pharmaphorum.com/2010/08/13/what-are-ideas-made-of-brand-names/</link>
		<comments>http://www.pharmaphorum.com/2010/08/13/what-are-ideas-made-of-brand-names/#comments</comments>
		<pubDate>Fri, 13 Aug 2010 08:58:26 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[sales]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2547</guid>
		<description><![CDATA[Mike Rea returns to question whether sufficient consideration is put into drug brand names. Are we playing it too safe?  

This is not an industry that does what is easy instead of what is best.
This is not an industry that would ever...
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/13/what-are-ideas-made-of-brand-names/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Understanding “strategy”</title>
		<link>http://www.pharmaphorum.com/2010/08/05/understanding-%e2%80%9cstrategy%e2%80%9d/</link>
		<comments>http://www.pharmaphorum.com/2010/08/05/understanding-%e2%80%9cstrategy%e2%80%9d/#comments</comments>
		<pubDate>Thu, 05 Aug 2010 08:48:45 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[strategy]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2481</guid>
		<description><![CDATA[Welcoming back a previous author now in a new role, pharmaphorum finds Pete West perplexed to find so many people talking at cross-purposes about strategy.

Have you ever been half way through a conversation with someone and suddenly realised that the thing you thought you were discussing...
]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/05/understanding-%e2%80%9cstrategy%e2%80%9d/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>How about considering profitable segmentation?</title>
		<link>http://www.pharmaphorum.com/2010/08/03/how-about-considering-profitable-segmentation/</link>
		<comments>http://www.pharmaphorum.com/2010/08/03/how-about-considering-profitable-segmentation/#comments</comments>
		<pubDate>Tue, 03 Aug 2010 09:08:38 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[strategy]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2463</guid>
		<description><![CDATA[As competition continues to increase within the pharmaceutical world, Dr. Andree Bates advises on the benefits of customer segmentation and targeted marketing. 

In today’s dynamic and competitive pharmaceutical environment, being able to effectively target your…]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/08/03/how-about-considering-profitable-segmentation/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>What Are IDEAs Made Of: Communications</title>
		<link>http://www.pharmaphorum.com/2010/07/30/what-are-ideas-made-of-communications/</link>
		<comments>http://www.pharmaphorum.com/2010/07/30/what-are-ideas-made-of-communications/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 08:32:53 +0000</pubDate>
		<dc:creator>Rebecca</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[strategy]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2499</guid>
		<description><![CDATA[As means and methods of communications expand, Mike Rea asks whether we are focusing too much on the how and losing sight of the what.

It used to be that those involved in the process of communication understood which part of the process they were delivering against. Whether you use...]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/07/30/what-are-ideas-made-of-communications/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>New UK joint working initiative addresses heart disease</title>
		<link>http://www.pharmaphorum.com/2010/07/27/new-uk-joint-working-initiative-addresses-heart-disease/</link>
		<comments>http://www.pharmaphorum.com/2010/07/27/new-uk-joint-working-initiative-addresses-heart-disease/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 09:29:03 +0000</pubDate>
		<dc:creator>Paul</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[CV]]></category>
		<category><![CDATA[government]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[joint working]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[UK]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2446</guid>
		<description><![CDATA[Attending the launch of the UK’s ‘Partners in Health’ initiative, Paul Tunnah finds healthcare collaboration looking longer term beyond just drug intervention.

The old saying goes that “prevention is better than a cure” and, as words of wisdom go, it’s hard to disagree with in...]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/07/27/new-uk-joint-working-initiative-addresses-heart-disease/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Lessons from the past, optimism for the future</title>
		<link>http://www.pharmaphorum.com/2010/07/22/lessons-from-the-past-optimism-for-the-future/</link>
		<comments>http://www.pharmaphorum.com/2010/07/22/lessons-from-the-past-optimism-for-the-future/#comments</comments>
		<pubDate>Thu, 22 Jul 2010 10:03:31 +0000</pubDate>
		<dc:creator>Paul</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Commercial]]></category>
		<category><![CDATA[Interviews]]></category>
		<category><![CDATA[career]]></category>
		<category><![CDATA[joint working]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[UK]]></category>

		<guid isPermaLink="false">http://www.pharmaphorum.com/?p=2416</guid>
		<description><![CDATA[In our latest interview Paul Tunnah talks to Nigel Brooksby, a well known figure in UK pharma, to hear his advice for the next generation of industry leaders.

One could be forgiven sometimes for thinking that there has never been a more challenging time to work in the pharma industry... ]]></description>
		<wfw:commentRss>http://www.pharmaphorum.com/2010/07/22/lessons-from-the-past-optimism-for-the-future/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
